Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EBIT Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 69.62-19.54-53.8883.2520.80

What is the latest EBIT Growth ratio of AUROBINDO PHARMA ?

The latest EBIT Growth ratio of AUROBINDO PHARMA is 69.62 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202469.62
Mar2023-19.54
Mar2022-53.88
Mar202183.25
Mar202020.80

How is EBIT Growth of AUROBINDO PHARMA Trending?

Years EBIT Growth % Change
Mar2024 69.62
Positive
Mar2023 -19.54
Negative
Mar2022 -53.88
Negative
Mar2021 83.25
300.24
Mar2020 20.8 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EBIT Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹65,912.1 Cr -5% 5.1% 8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-5%

5.1%

8.4%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses